Anika Therapeutics, Inc. (NASDAQ:ANIK)

CAPS Rating: 3 out of 5

The Company develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.

Recs

0
Player Avatar OklaBoston (68.08) Submitted: 11/23/2012 4:04:42 PM : Outperform Start Price: $9.66 ANIK Score: +2.81

A stock my pet formula says is worth more than it's 52 week high, and has 18% insider ownership is something I have to five a green thumb to, never mind the currently crappy charts.

Featured Broker Partners


Advertisement